Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Infigratinib companion diagnostic - Foundation Medicine

Next Previous
Drug Profile

Infigratinib companion diagnostic - Foundation Medicine

Alternative Names: Infigratinib F1CDx - Foundation Medicine; Infigratinib FoundationOne® CDx; Truseltiq companion diagnostic - Foundation Medicine; Truseltiq F1CDx - Foundation Medicine

Latest Information Update: 01 Jun 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Foundation Medicine
  • Class Diagnostic agents
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Registered Cholangiocarcinoma

Most Recent Events

  • 28 May 2021 First global approval - Registered for Cholangiocarcinoma (Diagnosis) in USA (unspecified route)
  • 29 Sep 2020 Preregistration for Cholangiocarcinoma (Diagnosis) in USA (unspecified route)
  • 10 Dec 2018 QED Therapeutics enters into an agreement with Foundation Medicine to develop a companion diagnostic for infigratinib for cholangiocarcinoma

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top